CD28-mediated co-stimulation: a quantitative support for TCR signalling.
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“In mouse and human T cells the dimeric transmembrane glycoprotein CD28 represents the most important co-stimulatory molecule.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 6×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialTOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,924
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialThe lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475 · cited 1×
“CD28-induced activation of AKT upregulates glucose metabolis”
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialCD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023 · cited 1×
“This is also indicated by studies showing that CD28 ligation lowers the number of triggered TCRs that are required for a given respons”
Background
Cited by
Items 101–200 of 797
Petersen, C. T., Hassan, M., Morris, A. B., Jeffery, J., Lee, K., Jagirdar, N., Staton, A. D., Raikar, S. S., Spencer, H. T., Sulchek, T., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017011254 · Cited by 116
“The loss of CD28 from T cells is particularly relevant to novel therapies employing autologous T cells genetically modified to express a tumor-specific antigen receptor, as many of the currently used manufacturing methods use anti-CD3/CD28 bead-mediated stimulation,(31) and signaling through CD3 in the absence of a co…”
BackgroundA variable immunoreceptor in a subpopulation of human neutrophils
Püellmann, K., Kaminski, W. E., Vogel, M., Nebe, C. T., Schroeder, J. A., Wolf, H. J., & Beham, A. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603406103 · Cited by 110
Kim, J., & White, F. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2833 · Cited by 122
Cofilin: a redox sensitive mediator of actin dynamics during T‐cell activation and migration
Samstag, Y., John, I., & Wabnitz, G. H. (2013) · Immunological Reviews · doi:10.1111/imr.12115 · Cited by 107
Dynamic regulation of T‐cell costimulation through TCR–CD28 microclusters
Yokosuka, T., & Saito, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00779.x · Cited by 106
Signal Transduction in Natural Killer Cells
Macfarlane, A. W., & Campbell, K. S. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_2 · Cited by 116
“respectively, are also thought to be derived mainly from recruitment of PI3K [4, 30].”
BackgroundDas, L., & Levine, A. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1490 · Cited by 116
“These and many other examples, which include CD28 and ICOS costimulation (58, 59), indicate that the TCR complex can initiate a variety of distinct signaling pathways that determine the specific outcome of Ag recognition.”
BackgroundCalcium-dependent activation of T-lymphocytes
Quintana, A., Griesemer, D., Schwarz, E. C., & Hoth, M. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-004-1364-4 · Cited by 120
“CD28 stimulation results in the activation of some, but not all, proteins that are stimulated through the TCR, yielding a model in which CD28 costimulation works as an amplifier of TCR stimulation [2].”
BackgroundCARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond
Chang, Z. L., & Chen, Y. Y. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.002 · Cited by 103
“The intensity of the costimulatory signal required for proper T-cell activation has been observed to vary inversely with the extent of TCR stimulation [31].”
Mazzarella, G., Stefanile, R., Camarca, A., Giliberti, P., Cosentini, E., Marano, C., Iaquinto, G., Giardullo, N., Auricchio, S., Sette, A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.008 · Cited by 116
Rother, N., & van der Vlag, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00610 · Cited by 105
Waight, J. D., Chand, D., Dietrich, S., Gombos, R., Horn, T., Gonzalez, A. M., Manrique, M., Swiech, L., Morin, B., Brittsan, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.005 · Cited by 104
Xia, H., Qin, M., Wang, Z., Wang, Y., Chen, B., Wan, F., Tang, M., Pan, X., Yang, Y., Liu, J., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00185 · Cited by 104
Tang, M., Chen, B., Xia, H., Pan, M., Zhao, R., Zhou, J., Yin, Q., Wan, F., Yan, Y., Fu, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41592-0 · Cited by 111
“Upregulation of costimulators, antigen presentation and secretion of proin fl ammatory cytokines contribute to cytotoxic T cell activation 30 .”
Mercier, B. C., Cottalorda, A., Coupet, C., Marvel, J., & Bonnefoy, N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801167 · Cited by 103
“Furthermore, it was shown that CD28 engagement allows lymphocyte activation in the presence of weak agonists (6, 7).”
BackgroundCD28 costimulatory signal induces protein arginine methylation in T cells
Blanchet, F., Cardona, A., Letimier, F. A., Hershfield, M. S., & Acuto, O. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050176 · Cited by 102
“TCR stimulation alone is insufficient to drive full T cell expansion and differentiation; this limit is overcome by CD28 coengagement that favors a sequential activation of thousands of genes (1).”
BackgroundInfluentialSelf-citationCD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response
Martínez-Llordella, M., Esensten, J. H., Bailey-Bucktrout, S. L., Lipsky, R. H., Marini, A., Chen, J., Mughal, M., Mattson, M. P., Taub, D. D., & Bluestone, J. A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122387 · Cited by 107
“, 2005) or the temporal changes in the gene transcription during the initial hours after T cell activation (Ellisen et al., 2001; Acuto and Michel, 2003).”
Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
Chan, K. R., Wang, X., Saron, W. A. A., Gan, E. S., Tan, H. C., Mok, D. Z. L., Zhang, S. L.-X., Lee, Y. H., Liang, C., Wijaya, L., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.164 · Cited by 112
Regulation of immune responses by E3 ubiquitin ligase Cbl-b
Tang, R., Langdon, W. Y., & Zhang, J. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.11.002 · Cited by 107
“Optimal T cell activation not only requires signal 1 through the TCR, but also signal 2 through the CD28 costimulatory receptor, and that CD28 costimulation can amplify TCR signaling [38].”
BackgroundDNA origami–based artificial antigen-presenting cells for adoptive T cell therapy
Sun, Y., Sun, J., Xiao, M., Lai, W., Li, L., Fan, C., & Pei, H. (2022) · Science Advances · doi:10.1126/sciadv.add1106 · Cited by 106
“These results disclose that complete T cell activation requires both TCR triggering and costimulation signal, which agrees well with the generally accepted two-signal model of lymphocyte activation ( 36 , 37 ).”
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
Perrier, A., Didelot, A., Laurent‐Puig, P., Blons, H., & Garinet, S. (2020) · Biomolecules · doi:10.3390/biom10071061 · Cited by 111
“CTLA-4 interacts with CD80 and CD86 with more affinity and avidity than CD28 and transmits an inhibitory signal to T cells [23–28], while CD28 transmits a stimulation signal [29,30].”
BackgroundRonchetti, S., Nocentini, G., Bianchini, R., Krausz, L. T., Migliorati, G., & Riccardi, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5916 · Cited by 100
“CD28 was the first costimulatory molecule to be identified and it has been shown to synergize with the TCR to lower the threshold of T cell activation, which is not attainable by ligation of the TCR alone (6).”
BackgroundCD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment
Lei, X., Khatri, I., de Wit, T., de Rink, I., Nieuwland, M., Kerkhoven, R. M., van Eenennaam, H., Sun, C., Garg, A. D., Borst, J. G., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35615-5 · Cited by 109
Pech, M. F., Fong, L. E., Villalta, J. E., Chan, L. J., Kharbanda, S., O’Brien, J. J., McAllister, F. E., Firestone, A. J., Jan, C. H., & Settleman, J. E. (2019) · eLife · doi:10.7554/elife.47362 · Cited by 104
Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory
Viaud, S., Ma, J. S. Y., Hardy, I. R., Hampton, E. N., Benish, B., Sherwood, L., Núñez, V., Ackerman, C. J., Khialeeva, E., Weglarz, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810060115 · Cited by 104
“As CD3ζ also signals through PI3-kinase (41), CD3ζ ITAM functionality could be dispensable in a CAR construct harboring CD28, but not in a 4–1BB-based construct.”
BackgroundDeletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Trefny, M. P., Kirchhammer, N., der Maur, P. A., Natoli, M., Schmid, D., Germann, M., Fernandez-Rodriguez, L., Herzig, P., Lötscher, J., Akrami, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35583-w · Cited by 103
Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells
Peters, C., Oberg, H., Kabelitz, D., & Wesch, D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1467-1 · Cited by 96
“CD28 signaling results in a phosphoinositide 3 kinase (PI3 K)-dependent phosphorylation of the serine/threonine kinase akt and an activation of nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells (NF-κB), thereby influencing cell survival [36].”
BackgroundCostimulatory receptors in jawed vertebrates: Conserved CD28, odd CTLA4 and multiple BTLAs
BERNARD, D., Hansen, J. A., DuPasquier, L., Lefranc, M., Benmansour, A., & Boudinot, P. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2006.06.003 · Cited by 100
“for immunity (reviewed in [1,2]).”
Space flight affects motility and cytoskeletal structures in human monocyte cell line J‐111
Meloni, M. A., Galleri, G., Pani, G., Saba, A., Pippia, P., & Cogoli‐Greuter, M. (2011) · Cytoskeleton · doi:10.1002/cm.20499 · Cited by 97
“Many cell surface receptors are able to enhance signaling through the TCR/CD3 complex, but CD 28 is the most efficient [Acuto and Michel, 2003].”
BackgroundSequence, structure, function, immunity: structural genomics of costimulation
Chattopadhyay, K., Lázár‐Molnár, E., Yan, Q., Rubinstein, R., Zhan, C., Vigdorovich, V. I., Ramagopal, U. A., Bonanno, J. B., Nathenson, S. G., & Almo, S. C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00778.x · Cited by 98
“main effects of CD28 signaling are to augment and sustain T-cell responses, promote survival of T cells and direct cytokine production for the induction of clonal expansion and differentiation (29).”
BackgroundTai, X., Van Laethem, F., Sharpe, A. H., & Singer, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706509104 · Cited by 91
CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Kong, Y., Li, J., Zhao, X., Wu, Y., & Chen, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1519671 · Cited by 119
CD28 co‐signaling in the adaptive immune response
Riha, P., & Rudd, C. E. (2010) · Self/Nonself · doi:10.4161/self.1.3.12968 · Cited by 87
Ribot, J. C., deBarros, A., Mancio-Silva, L., Pamplona, A., & Silva-Santos, B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200268 · Cited by 85
Polymer- and lipid-based gene delivery technology for CAR T cell therapy
Pinto, I. S., Cordeiro, R. A., & Faneca, H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.038 · Cited by 96
Krueger, A., Fas, S. C., Giaisi, M., Bleumink, M., Merling, A., Stumpf, C., Baumann, S., Holtkotte, D., Bosch, V., Krammer, P. H., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2567 · Cited by 89
“The HRPO-conjugated goat anti– mouse IgG1, IgG2a, and IgG2b were from Southern Biotechnology Associates (Birmingham, AL), and the polyclonal anti-Bid (p15) antibody (44-433) was from Biosource (Camarillo, CA).”
MethodImmunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases
Xu, Y., Li, J., Ferguson, G. D., Mercurio, F., Khambatta, G., Morrison, L., Lopez-Girona, A., Corral, L. G., Webb, D. R., Bennett, B. L., et al. (2009) · Blood · doi:10.1182/blood-2009-02-200543 · Cited by 87
Trogocytosis of CD80 and CD86 by induced regulatory T cells
Gu, P., Gao, J. F., D’Souza, C. A., Kowalczyk, A., Chou, K., & Zhang, L. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.62 · Cited by 93
Zaunders, J., Ip, S., Munier, C. M. L., Kaufmann, D., Suzuki, K., Brereton, C., Sasson, S. C., Seddiki, N., Koelsch, K. K., LANDAY, A. L., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00249-06 · Cited by 101
“The rapid expression of CTLA-4 in response to HIV-1 Gag antigen would be predicted to interfere with CD28 signaling (11, 36), reducing the synthesis and stability of IL-2 mRNA (2).”
BackgroundStromnes, I. M., Blattman, J. N., Tan, X., Jeevanjee, S., Gu, H., & Greenberg, P. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41991 · Cited by 85
Chemnitz, J. M., Lanfranco, A. R., Braunstein, I., & Riley, J. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6603 · Cited by 85
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
Lotze, M. T., Olejniczak, S. H., & Skokos, D. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01061-1 · Cited by 91
“In the two decades from the mid-1990s to the mid-2010s, much knowledge surrounding CD28 was generated and has been expertly reviewed elsewhere 12,33,34 (Fig.”
Targeting ubiquitin signaling for cancer immunotherapy
Zhou, X., & Sun, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00421-2 · Cited by 100
The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease
Weyand, C. M., Berry, G. J., & Goronzy, J. J. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ma0717-283 · Cited by 92
T cell engagers: expanding horizons in oncology and beyond
Albayrak, G., Wan, P. K.-T., Fisher, K. D., & Seymour, L. W. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03125-y · Cited by 95
“This design directly tackles the issue that T cells require not just TCR signalling (often called ‘ Signal 1 ’ ) but also a co-stimulatory signal ( ‘ Signal 2 ’ , such as via CD28) for full activation, proliferation, and sustained killing function [21].”
Beyersdorf, N., Hanke, T., Kerkau, T., & Hünig, T. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042564 · Cited by 98
Haile, S. T., Dalal, S. P., Clements, V. K., Tamada, K., & Ostrand‐Rosenberg, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202777 · Cited by 89
“To further examine the possibility that costimulation is involved, we compared T cell activation in the presence of CD80-Fc versus CD86-Fc because CD86 also costimulates via CD28 (36) and is three to five times more effective at costimulating than CD80 (37, 38) but does not bind PDL1 (4).”
Characterization of the metabolic phenotype of chronically activated lymphocytes
Wahl, D., Petersen, B., Warner, R., Richardson, B., Glick, G., & Opipari, A. (2010) · Lupus · doi:10.1177/0961203310373109 · Cited by 82
Rodriguez, G. M., Bobbala, D., Serrano, D., Mayhue, M., Champagne, A., Saucier, C., Steimle, V., Kufer, T. A., Menéndez, A., Ramanathan, S., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1151593 · Cited by 89
“B16-80 cells also induced strong proliferation of Pmel-1 cells in the presence of mgp100, presumably by delivering co-stimulatory signals that supplement the basal TCR signaling.(37) However, B16-5/80 cells did not elicit a response superior to B16-5 cells.”
BackgroundFann, M., Chiu, W. K., Wood, W. H., Levine, B. L., Becker, K. G., & Weng, N. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00262.x · Cited by 81
“activation of T cells after stimulation with antigen (10, 11).”
BackgroundCook, A., McDonnell, A. M., Lake, R., & Nowak, A. K. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1066062 · Cited by 88
“The inducible co-stimulator molecule (ICOS), a member of the CD28 family of co-stimulatory molecules, is expressed on activated T cells, and has been described as an indicator of antigen-specific activation.(9,10) An increasing proportion of Tregs were seen to express ICOS in response to Dex, whereas the ICOS-expressi…”
BackgroundMetabolic Adaptation of Human CD4+ and CD8+ T-Cells to T-Cell Receptor-Mediated Stimulation
Jones, N., Cronin, J., Dolton, G. M., Panetti, S., Schauenburg, A. J. A., Galloway, S. A. E., Sewell, A. K., Cole, D. K., Thornton, C. A., & Francis, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01516 · Cited by 91
Esparza, E. M., & Arch, R. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7869 · Cited by 81
“CD28 is a major costimulatory receptor on naive T cells that promotes the expression of cytokines and drives cell cycle progression (14).”
BackgroundT-cell co-stimulatory pathways in autoimmunity
Goronzy, J. J., & Weyand, C. M. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2414 · Cited by 89
Li, Q., Yan, Y., Liu, J., Huang, X., Zhang, X., Kirschning, C. J., Xu, H. C., Lang, P. A., Dittmer, U., Zhang, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02191 · Cited by 87
“T cells that exert optimal effector functions rely on multiple signals, specifically via TCR, co-stimulatory molecules, and pro-inflammatory cytokines (45, 46).”
BackgroundSanchez-Lockhart, M., Marin, E., Graf, B., Abe, R., Harada, Y., Sedwick, C. E., & Miller, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7120 · Cited by 79
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
Waibler, Z., Sender, L. Y., Merten, C., Hartig, R., Kliche, S., Gunzer, M., Reichardt, P., Kalinke, U., & Schraven, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001708 · Cited by 79
“. In mouse and human T cells the dimeric transmembrane glycoprotein CD28 represents the most important co-stimulatory molecule. Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80…”
BackgroundThe molecular machinery for cAMP-dependent immunomodulation in T-cells
Taskén, K., & Stokka, A. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340476 · Cited by 79
Regulation of NF-κB induction by TCR/CD28
Cheng, J., Montecalvo, A., & Kane, L. (2011) · Immunologic Research · doi:10.1007/s12026-011-8216-z · Cited by 79
“The scientific literature reflects a long debate on the question whether the TCR and the co-receptors induce separate signal pathways (qualitative model) or whether the signaling routes employed by both receptor systems are entirely overlapping (quantitative model) [32].”
BackgroundExtracellular Vesicles and Tumor-Immune Escape: Biological Functions and Clinical Perspectives
Raimondo, S., Pucci, M., Alessandro, R., & Fontana, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072286 · Cited by 80
B‐cell activation in patients with irritable bowel syndrome (IBS)
öhman, L., Lindmark, A. ‐., Isaksson, S., Posserud, I., Strid, H., Sjövall, H., & Simrén, M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01272.x · Cited by 78
Tian, R., Wang, H., Gish, G. D., Petsalaki, E., Pasculescu, A., Shi, Y., Mollenauer, M., Bagshaw, R. D., Yosef, N., Hunter, T., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503286112 · Cited by 76
“Another is that, once two cells adhere to one another, they may interact through multiple different ligands and receptors, making it difficult to confidently define the exclusive signaling output of a single class of receptor (9, 11).”
BackgroundExploiting Apoptosis for Therapeutic Tolerance Induction
Getts, D. R., McCarthy, D. P., & Miller, S. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302070 · Cited by 79
“cilitate TCR signal transduction at the IS (57, 58).”
BackgroundPersistent Luminescence Immune Hydrogel for Photodynamic‐Immunotherapy of Tumors In Vivo
Shu, G., Zhu, W., Jiang, Y., Li, X., Pan, J., Zhang, X., Zhang, X., & Sun, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104472 · Cited by 78
Costimulatory Receptors in a Teleost Fish: Typical CD28, Elusive CTLA4
Bernard, D., Riteau, B., Hansen, J. D., Phillips, R. B., Michel, F., Boudinot, P., & Benmansour, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4191 · Cited by 76
Self-citationFlavonoid Naringenin: A Potential Immunomodulator for Chlamydia trachomatis Inflammation
Yilma, A. N., Singh, S. R., Morici, L. A., & Dennis, V. A. (2013) · Mediators of Inflammation · doi:10.1155/2013/102457 · Cited by 75
“The CD28mediated costimulatory signal can result in an enhanced T-cell proliferation and cytokine production which contributes to the development of various inflammatory diseases [40–42].”
BackgroundChen, L. C., Delgado, J. C., Jensen, P. E., & Chen, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901081 · Cited by 79
“Activation of all necessary nuclear factors may require costimulation through CD28, which amplifies TCR activation-induced intracellular signaling (58, 59).”
BackgroundCD28 and ICOS: Similar or separate costimulators of T cells?
van Berkel, M. E. A. T., & Oosterwegel, M. A. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.02.007 · Cited by 84
Parry, R. V., & Ward, S. G. (2005) · Wiley eBooks · doi:10.1038/npg.els.0001184 · Cited by 74
Signal transduction and Th17 cell differentiation
O'Shea, J. J., Steward-Tharp, S. M., Laurence, A., Watford, W. T., Wei, L., Adamson, A. S., & Fan, S. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.007 · Cited by 73
“In addition, signals from co-stimulatory molecules cooperate with TCR signaling to regulate full T cell activation (Acuto and Michel 2003).”
BackgroundRizzo, L. B., Do Prado, C. H., Grassi-Oliveira, R., Wieck, A., Correa, B. L., Teixeira, A. L., & Bauer, M. E. (2013) · Bipolar Disorders · doi:10.1111/bdi.12121 · Cited by 73
Immune checkpoint inhibitors: new strategies to checkmate cancer
Wilson, R. A. M., Evans, T. R. J., Fraser, A. R., & Nibbs, R. J. B. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13081 · Cited by 70
“‘Signal one’ comes from the T cell receptor (TCR) after it engages cognate antigen displayed on target cell MHC, but secondary positive signals (co-stimulation) are also essential, while further signals through cytokine receptors shape effector T-cell phenotype [15-18].”
BackgroundNair, P., Melarkode, R., Rajkumar, D., & Montero, E. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04235.x · Cited by 84
Early Kinetic Window of Target T Cell Susceptibility to CD25+ Regulatory T Cell Activity
Sojka, D. K., Hughson, A., Sukiennicki, T. L., & Fowell, D. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7274 · Cited by 70
“It is unclear whether CD28 engagement leads to a qualitatively different T cell signal or whether it simply amplifies the TCR signal cascade (32).”
BackgroundHe, S., Kato, K., Jiang, J., Wahl, D. R., Mineishi, S., Fisher, E. M., Murasko, D. M., Glick, G. D., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020107 · Cited by 68
“To test this hypothesis, we analyzed OXPHOS in antigen-activated T cells by measuring their oxygen consumption [40,41,42,43].”
MethodSearching for “signal 2”: costimulation requirements of γδ T cells
Ribot, J. C., deBarros, A., & Silva‐Santos, B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0698-2 · Cited by 76
“This is critically reflected in the impaired immune responses mounted by CD28-deficient mice against a variety of infectious agents (reviewed in [2]).”
BackgroundT-cell-targeted therapies in rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0142 · Cited by 77
“As a rule, TCR-mediated signals are combined with co-stimulatory signals”
BackgroundStable human regulatory T cells switch to glycolysis following TNF receptor 2 costimulation
de Kivit, S., Mensink, M., Hoekstra, A. T., Berlin, I., Derks, R. J. E., Both, D., Aslam, M. A., Amsen, D., Berkers, C. R., & Borst, J. G. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00271-w · Cited by 71
Bjørgo, E., Solheim, S. A., Abrahamsen, H., Baillie, G. S., Brown, K. M., Berge, T., Okkenhaug, K., Houslay, M. D., & Taskén, K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00696-09 · Cited by 65
“The second signal is typically elicited by ligands B7-1 or B7-2 on antigen-presenting cells engaging the coreceptor CD28 to prevent anergy and apoptosis and enhancing interleukin-2 (IL-2) production and clonal expansion (4).”
BackgroundInfluentialFrom immune checkpoints to vaccines: The past, present and future of cancer immunotherapy
Osipov, A., Murphy, A. G., & Zheng, L. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.002 · Cited by 77
Vessillier, S., Eastwood, D., Fox, B. J., Sathish, J. G., Sethu, S., Dougall, T., Thorpe, S. J., Thorpe, R., & Stebbings, R. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.04.020 · Cited by 76
“…cytokine release without simultaneous engagement of the T cell receptor, which restricts responses to antigen-specific cells which typically comprise only 0.01–1.0% of the total T cell population (Acuto and Michel, 2003; Rudd and Schneider, 2003; Harari et al., 2004; Calarota and Baldanti, 2013).”
BackgroundInfluentialControlling NF-κB activation in T cells by costimulatory receptors
Schmitz, M. L., & Krappmann, D. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401845 · Cited by 82
“impaired responses to immune challenges such as a compromised Th2 development, immunoglobulin class switching and an increased susceptibility to various infectious pathogens.(13) The paramount importance of CD28 for the efficient functioning of the T cell response is also reflected by the finding that some inflammator…”
BackgroundORAI-mediated calcium influx in T cell proliferation, apoptosis and tolerance
Qu, B., Alansary, D., Kummerow, C., Hoth, M., & Schwarz, E. C. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.05.015 · Cited by 72
Keller, A. M., Xiao, Y., Peperzak, V., Naik, S. H., & Borst, J. G. (2009) · Blood · doi:10.1182/blood-2008-03-148007 · Cited by 68
Immunosuppressive Effects of Erythropoietin on Human Alloreactive T Cells
Cravedi, P., Manrique, J., Hanlon, K. E., Reid‐Adam, J., Brody, J., Prathuangsuk, P., Mehrotra, A., & Heeger, P. S. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090945 · Cited by 68
Soldevilla, M. M., Villanueva, H., Casares, N., Lasarte, J. J., Bendandi, M., Inoges, S., de Cerio, A. L.-D., & Pastor, F. (2016) · Oncotarget · doi:10.18632/oncotarget.8095 · Cited by 68
“CD28 has been underscored as one of the major costimulatory receptors on T lymphocytes, promoting proliferation and cell differentiation into effector T cells [17].”
BackgroundImpaired apoptosis and immune senescence – cause or effect?
Hsu, H., Scott, D. K., & Mountz, J. D. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00270.x · Cited by 67
“In addition to the protein tyrosine kinases Lck, Fyn, and Tek, recruited upon TCR engagement of MHC plus antigen, CD28 induces the PI3K activity, which signals Akt, as well as the Rho family, guanine nucleotide exchange factor (GEF), VAV1, and the E3 ubiquitin ligase Cbl-b (91, 92).”
BackgroundAbatacept for the treatment of rheumatoid arthritis
Pombo‐Suárez, M., & Gómez-Reino, J. J. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1579642 · Cited by 67
“The CD28 ligation of naïve T-cells is essential for IL-2 production and cell proliferation [9] (Figure 1(a)).”
BackgroundZhang, M., Long, H., & Sun, L. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.03.005 · Cited by 67
T Cell Co-stimulation and Functional Modulation by Innate Signals
Imanishi, T., & Saito, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.01.003 · Cited by 70
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.010 · Cited by 69
Watanabe, M., Fujihara, C., Radtke, A. J., Chiang, Y. J., Bhatia, S., Germain, R. N., & Hodes, R. J. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161955 · Cited by 70
“The requirement for CD28 co-stimulation in T cell activation has been shown to be critically dependent on the strength of primary TCR-mediated antigenic signaling, with strong TCR signaling associated with a decreased requirement for co-stimulation (Acuto and Michel, 2003).”
BackgroundThe Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy
Michie, J., Kearney, C. J., Hawkins, E. D., Silke, J., & Oliaro, J. (2020) · Cells · doi:10.3390/cells9010207 · Cited by 73
“T cell activation also requires co-stimulation through the interaction of the T cell receptor, CD28, and the membrane bound glycoproteins, CD80 or CD86, expressed on professional antigen presenting cells, such as dendritic cells [75].”
BackgroundMechanisms of Irritant and Allergic Contact Dermatitis
Rustemeyer, T., van Hoogstraten, I. M. W., Blomberg, B. M. E. V., Gibbs, S., & Scheper, R. J. (2010) · Springer eBooks · doi:10.1007/978-3-642-03827-3_3 · Cited by 66
Vaccine therapy for pancreatic cancer
Salman, B., Zhou, D., Jaffee, E. M., Edil, B. H., & Zheng, L. (2013) · OncoImmunology · doi:10.4161/onci.26662 · Cited by 64
“Most malignant cells lack the necessary surface molecules, that is, B7-1 (CD80) and B7-2 (CD86), to complete signal 2.(9) By contrast, cell surface molecules such as CTLA-4, PD-1, and PD-L1 (B7-H1) and PD-L2 (B7-DC) are expressed to activate immune checkpoint signaling pathways and thereby downregulate T-cell activati…”
BackgroundThe T‐cell fingerprint of MALT 1 paracaspase revealed by selective inhibition
Bardet, M., Unterreiner, A., Malinverni, C., Lafossas, F., Vedrine, C., Boesch, D., Kolb, Y., Kaiser, D., Glück, A., Schneider, M. A., et al. (2018) · Immunology & Cell Biology · doi:10.1111/imcb.1018 · Cited by 60
“After TCR pathway engagement, several markers become detectable at the plasma membrane and their expression level can be read out as a measure of T-cell activation.(31) Pan-protein kinase C inhibition by AEB071 abolished induced surface expression of CD25 (IL2Ra), CD69, OX40 and ICOS in response to a range of anti-CD3…”
BackgroundMechanisms of CTLA-4-Ig in Tolerance Induction
Alegre, M., & Fallarino, F. (2005) · Current Pharmaceutical Design · doi:10.2174/138161206775193046 · Cited by 67
Aptamer-Based Therapeutic Approaches to Target Cancer Stem Cells
Zhou, G., Latchoumanin, O., Bagdesar, M., Hebbard, L., Duan, W., Liddle, C., George, J., & Qiao, L. (2017) · Theranostics · doi:10.7150/thno.20725 · Cited by 66
“The interaction of co-stimulatory molecules (such as 4-1BB, CD28 and OX40) with their cognate ligands is essential for the activation of T lymphocytes [83].”
BackgroundAllie, S. R., & Randall, T. D. (2017) · Clinical Science · doi:10.1042/cs20160259 · Cited by 74
Tec kinases, actin, and cell adhesion
Gómez‐Rodríguez, J., Readinger, J. A., Viorritto, I. C. B., Mueller, K. L., Houghtling, R. A., & Schwartzberg, P. L. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00534.x · Cited by 68
“CD28 is thought to amplify TCR-based signals through PI3K activation and lipid raft recruitment (146).”
Background
Metadata
- Authors
- Acuto, O., & Michel, F.
- Affiliations
- Institut Pasteur (FR)
- Corresponding author
- Acuto, Oreste
- ORCID
- Michel, Frédérique
- Venue
- Nature Reviews Immunology
- Published
- 2003-12
- Volume
- 3
- Issue
- 12
- Pages
- 939-951
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2055248228
- Cited by
- 775
- References
- 157
- Citations by year
- 2026: 26 · 2025: 32 · 2024: 31 · 2023: 23 · 2022: 42 · 2021: 33 · 2020: 32 · 2019: 25 · 2018: 38 · 2017: 43 · 2016: 42 · 2015: 35 · 2014: 29 · 2013: 37 · 2012: 33
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD28, costimulation, T cell receptor signaling, T cell activation, naive T cells, clonal expansion, costimulatory receptors, signal amplification
- MeSH terms
- Animals, Carrier Proteins, Cell Cycle, Humans, Lymphocyte Activation, Membrane Proteins, Phosphoproteins, T-Lymphocytes, Signal Transduction, CD28 Antigens, Phosphatidylinositol 3-Kinases, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.